The pharmacokinetics of cyclosporine A in uremic patients.

Suppr

超能文献

作者信息

Lindberg A, Odlind B, Tufveson G, Lindström B, Gabrielsson J

出版信息

Transplant Proc. 1986 Dec;18(6 Suppl 5):144-52.

PMID:3787709

Abstract

摘要

相似文献

The pharmacokinetics of cyclosporine A in uremic patients.

Transplant Proc. 1986 Dec;18(6 Suppl 5):144-52.

The effect of obesity on cyclosporine pharmacokinetics in uremic patients.

Transplant Proc. 1989 Feb;21(1 Pt 2):1446-8.

Comparison of oral and intravenous cyclosporine A in kidney transplants.

Transplant Proc. 1987 Feb;19(1 Pt 2):1717-8.

Cyclosporine pharmacokinetics in uremic patients: influence of different assay methods.

Transplant Proc. 1988 Apr;20(2 Suppl 2):462-5.

Steady-state concentrations of cyclosporine for therapeutic monitoring.

Transplant Proc. 1990 Jun;22(3):1339-42.

Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio.

Transplant Proc. 1988 Jun;20(3 Suppl 3):361-5.

Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome.

Transplant Proc. 1988 Apr;20(2 Suppl 2):529-35.

Predominance of native cyclosporine over metabolites in rat blood and tissue.

Transplant Proc. 1988 Apr;20(2 Suppl 2):674-9.

Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.

Transplantation. 1985 Nov;40(5):483-8.

Cyclosporine kinetics in renal transplantation.

Clin Pharmacol Ther. 1985 Sep;38(3):296-300. doi: 10.1038/clpt.1985.174.

引用本文的文献

Cyclosporin clinical pharmacokinetics.

Clin Pharmacokinet. 1993 Jun;24(6):472-95. doi: 10.2165/00003088-199324060-00004.

Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.

Eur J Clin Pharmacol. 1994;47(1):61-5. doi: 10.1007/BF00193480.

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Drugs. 1993 Jun;45(6):953-1040. doi: 10.2165/00003495-199345060-00007.

Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.

Transplant Proc. 1986 Dec;18(6 Suppl 5):129-36.

Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.

Pharm Res. 1988 Feb;5(2):80-5. doi: 10.1023/a:1015932032609.

Clinical pharmacokinetics in organ transplant patients.

Clin Pharmacokinet. 1989 Mar;16(3):134-61. doi: 10.2165/00003088-198916030-00002.

Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

J Pharmacokinet Biopharm. 1990 Aug;18(4):293-311. doi: 10.1007/BF01062270.

A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.

Br J Clin Pharmacol. 1990 Sep;30(3):443-52. doi: 10.1111/j.1365-2125.1990.tb03796.x.

Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.

Eur J Clin Pharmacol. 1991;40(5):513-9. doi: 10.1007/BF00315232.

Therapeutic monitoring of cyclosporin--an update.

Eur J Clin Pharmacol. 1991;41(4):273-83. doi: 10.1007/BF00314952.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验